Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005022584 | SCV005651057 | likely pathogenic | Amelogenesis imperfecta type 1G | 2023-12-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005112690 | SCV005803798 | pathogenic | not provided | 2024-11-05 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 2 of the FAM20A gene. It does not directly change the encoded amino acid sequence of the FAM20A protein. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. This variant is present in population databases (rs779913321, gnomAD 0.07%). This variant has been observed in individual(s) with clinical features of enamel-renal syndrome (PMID: 37159186). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. Studies have shown that this variant results in skipping of exon 3, but is expected to preserve the integrity of the reading-frame (PMID: 37159186). For these reasons, this variant has been classified as Pathogenic. |